Silencing NOX4 or ROS inhibitors (DPI or NAC) treatment inhibited the increases in ROS, cytotoxicity, and caspase-3 activity in 8-shogaol-treated gastric cancer cells, meaning NOX4 as the regulator of 8-shogaol-mediated ROS production. The gene discussed is CASP3; the disease is gastric cancer.